Literature DB >> 27071658

LXR activation causes G1/S arrest through inhibiting SKP2 expression in MIN6 pancreatic beta cells.

Yating Li1, Changwen Jing1, Xinyi Tang1, Yuanyuan Chen1, Xiao Han1, Yunxia Zhu2.   

Abstract

Liver X receptors (LXRs) are nuclear hormone receptors with central roles in lipid homeostasis. We previously showed that LXR activation induced aberrant lipid metabolism and G1 cell cycle arrest in pancreatic beta cells. In this study, we aimed to identify the molecular target of LXR causing G1 arrest. LXR activation was induced by its agonist, T0901317. A series of luciferase reporters of truncated Skp2 promoter were analyzed in MIN6 cells. mRNA and protein levels of SKP2 and P27 were detected. Flow cytometry assay was used to determine the cell cycle distribution. MTT assay was used to evaluate cell viability. LXR activation increased cell distribution in G1 phase and lipid accumulation. Since dominant-negative Srebp1c could clear the deposited lipid rather than recover the G1 arrest, we identified S-phase kinase-associated protein 2 (Skp2) as a potential target gene of LXR. In deed, LXR activation significantly inhibited Skp2 gene expression and protein amount. We also observed that the luciferase activity of Skp2 promoter was suppressed by T0901317 and the potential LXR regulatory site was narrowed down to a region of nt -289 to -38. Silencing Lxrα and Lxrβ rescued SKP2 protein level and recovered the cellular growth repressed by LXR activation. Moreover, SKP2 overabundance reduced P27 protein level by promoting its degradation, consequently overcame the G1 arrest caused by T0901317. Our findings demonstrate that transrepressing Skp2 expression by LXR activation resulted in defective SKP2-mediated P27 degradation and inhibitory cell growth in beta cells.

Entities:  

Keywords:  Cell cycle arrest; Liver X receptors; Pancreatic beta cell; SKP2; Type 2 diabetes

Mesh:

Substances:

Year:  2016        PMID: 27071658     DOI: 10.1007/s12020-016-0915-8

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  49 in total

Review 1.  Beta-cell adaptation and decompensation during the progression of diabetes.

Authors:  G C Weir; D R Laybutt; H Kaneto; S Bonner-Weir; A Sharma
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

2.  MicroRNAs contribute to compensatory β cell expansion during pregnancy and obesity.

Authors:  Cécile Jacovetti; Amar Abderrahmani; Géraldine Parnaud; Jean-Christophe Jonas; Marie-Line Peyot; Marion Cornu; Ross Laybutt; Emmanuelle Meugnier; Sophie Rome; Bernard Thorens; Marc Prentki; Domenico Bosco; Romano Regazzi
Journal:  J Clin Invest       Date:  2012-09-10       Impact factor: 14.808

3.  Translational control of p27Kip1 accumulation during the cell cycle.

Authors:  L Hengst; S I Reed
Journal:  Science       Date:  1996-03-29       Impact factor: 47.728

4.  The nuclear receptor LXR is a glucose sensor.

Authors:  Nico Mitro; Puiying A Mak; Leo Vargas; Cristina Godio; Eric Hampton; Valentina Molteni; Andreas Kreusch; Enrique Saez
Journal:  Nature       Date:  2006-12-24       Impact factor: 49.962

5.  STAT1 represses Skp2 gene transcription to promote p27Kip1 stabilization in Ras-transformed cells.

Authors:  Shuo Wang; Jennifer F Raven; Antonis E Koromilas
Journal:  Mol Cancer Res       Date:  2010-04-20       Impact factor: 5.852

6.  Reciprocal negative cross-talk between liver X receptors (LXRs) and STAT1: effects on IFN-γ-induced inflammatory responses and LXR-dependent gene expression.

Authors:  Mónica Pascual-García; Laura Rué; Theresa León; Josep Julve; José María Carbó; Jonathan Matalonga; Herbert Auer; Antonio Celada; Joan Carles Escolà-Gil; Knut R Steffensen; Esther Pérez-Navarro; Annabel F Valledor
Journal:  J Immunol       Date:  2013-05-17       Impact factor: 5.422

7.  FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2.

Authors:  Tao Zuo; Runhua Liu; Huiming Zhang; Xing Chang; Yan Liu; Lizhong Wang; Pan Zheng; Yang Liu
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

8.  Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing.

Authors:  M Shirane; Y Harumiya; N Ishida; A Hirai; C Miyamoto; S Hatakeyama; K Nakayama; M Kitagawa
Journal:  J Biol Chem       Date:  1999-05-14       Impact factor: 5.157

9.  A transcription factor of lipid synthesis, sterol regulatory element-binding protein (SREBP)-1a causes G(1) cell-cycle arrest after accumulation of cyclin-dependent kinase (cdk) inhibitors.

Authors:  Masanori Nakakuki; Hitoshi Shimano; Noriyuki Inoue; Mariko Tamura; Takashi Matsuzaka; Yoshimi Nakagawa; Naoya Yahagi; Hideo Toyoshima; Ryuichiro Sato; Nobuhiro Yamada
Journal:  FEBS J       Date:  2007-07-27       Impact factor: 5.542

10.  The cytotoxic role of intermittent high glucose on apoptosis and cell viability in pancreatic beta cells.

Authors:  Zhen Zhang; Jing Li; Lei Yang; Rongping Chen; Rui Yang; Hua Zhang; Dehong Cai; Hong Chen
Journal:  J Diabetes Res       Date:  2014-03-17       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.